Monocacy Therapeutics Inc.
New Filing
CIK: 0002137361·Biotechnology·DELAWARE·Filed: Aug 28, 2026
Total Offering
$125,000
Amount Sold
$125,000
Investors
5
First Sale
N/A
Offering Details
- Type
- Other: Simple Agreement for Future Equity (SAFE)
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Year Incorporated
- 2025
- Non-Accredited Investors
- Yes
Related Persons
| Name | Role |
|---|---|
| Suman Vodnala | |
| Shashank Patel |
Company
SEC Filing
0002137361-26-000003
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free